Hopp til innhold
Close

Get alerts of updates about «Development and approval of coronavirus vaccine»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)
Do you also want alerts about:

The email address you register will only be used to send you these alerts. You can cancel and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

  • Development and approval of coronavirus vaccine

Oops, something went wrong...

... contact nettredaksjon@fhi.no.

... reload the page and try again-

Article

Development and approval of coronavirus vaccine

Published Updated

Several biotechnology companies, global vaccine manufacturers and other organisations are developing vaccines against COVID-19 disease.

Vaksine colurbox5428757.jpg

Several biotechnology companies, global vaccine manufacturers and other organisations are developing vaccines against COVID-19 disease.


Currently, no vaccine against the new coronavirus has been approved by the European Medicines Agency, and timelines are uncertain. There are a number of publications from the studies for the various vaccine candidates, but much of the supporting data that are necessary for a comprehensive assessment have not yet been published.

The Norwegian Medicines Agency assesses the clinical documentation and approves vaccines for use in Norway, in collaboration with the European Medicines Agency. Several different vaccines are likely to be approved during the pandemic period.

Vaccine technologies

Approval process

History

23.10.2020 Shortened text and added links to expanded information at Norwegian Medicines Agency

12.10.2020 Minor updates based on current knowledge. Link to Norwegian Medicines Agency

 

Skip to content on this page